Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS1M
Performance in the last:
Follow this Portfolio
1D 0.2 %
1W 2.7 %
2W -1.8 %
1M -3.3 %
3M -11.9 %
6M -83.7 %
9M -83.2 %
1Y -82.8 %
Alpha
-101.9%
Beta
0.73
sharpe-R
-0.94
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:50
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -86.08%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
AGEN Agenus Inc. Equity Buy 11.86% 13.89%
AADI Aadi Bioscience, Inc. Equity Buy 12.59% 5.14%
PODD Insulet Corporation Equity Buy 22.49% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 5.86% -2.73%
NVCR NovoCure Limited Equity Buy 19.71% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 9.65% 6.04%
STAA STAAR Surgical Company Equity Sell -6.24% 0.59%
AVXL Anavex Life Sciences Corp. Equity Sell -5.47% 7.14%
VREX Varex Imaging Corporation Equity Sell -5.5% 5.04%
CERS Cerus Corporation Equity Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 40.47%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.86% 13.89%
AADI Aadi Bioscience, Inc. Buy 12.59% 5.14%
PODD Insulet Corporation Buy 22.49% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.86% -2.73%
NVCR NovoCure Limited Buy 19.71% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.65% 6.04%
STAA STAAR Surgical Company Sell -6.24% 0.59%
AVXL Anavex Life Sciences Corp. Sell -5.47% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 40.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -8.6%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.69% 11.15%
AADI Aadi Bioscience, Inc. Buy 12.99% 7.43%
PODD Insulet Corporation Buy 22.55% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -3.83%
NVCR NovoCure Limited Buy 19.83% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.5% 3.45%
CDMO Avid Bioservices, Inc. Sell -6.84% -6.71%
STAA STAAR Surgical Company Sell -6.15% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.77% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.71% 2.37%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.62% -1.69%
AGEN Agenus Inc. Buy 10.79% -0.18%
AADI Aadi Bioscience, Inc. Buy 12.65% 1.71%
PODD Insulet Corporation Buy 22.45% 10.8%
TVTX Travere Therapeutics, Inc. Buy 8.37% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 5.92% -5.46%
NVCR NovoCure Limited Buy 19.19% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.47% 0.26%
CDMO Avid Bioservices, Inc. Sell -6.54% 0.85%
STAA STAAR Surgical Company Sell -6.07% 6.89%
AVXL Anavex Life Sciences Corp. Sell -5.21% 14.88%
VREX Varex Imaging Corporation Sell -5.84% 2.99%
CERS Cerus Corporation Sell -5.85% 2.84%
The percentage of cash held in the portfolio is: 30.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.72% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.67% -9.62%
AGEN Agenus Inc. Buy 10.03% -6.22%
AADI Aadi Bioscience, Inc. Buy 12.73% 3.43%
PODD Insulet Corporation Buy 21.5% 7.2%
TVTX Travere Therapeutics, Inc. Buy 8.29% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 5.75% -7.1%
NVCR NovoCure Limited Buy 18.67% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.41% 0.63%
CDMO Avid Bioservices, Inc. Sell -5.52% 15.41%
STAA STAAR Surgical Company Sell -5.99% 7.17%
AVXL Anavex Life Sciences Corp. Sell -5.31% 12.41%
VREX Varex Imaging Corporation Sell -5.21% 12.56%
CERS Cerus Corporation Sell -5.7% 4.27%
The percentage of cash held in the portfolio is: 20.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.15% 3%
CARA Cara Therapeutics, Inc. Buy 10.17% -6.12%
AGEN Agenus Inc. Buy 9.8% -9.51%
AADI Aadi Bioscience, Inc. Buy 13.03% 4.57%
PODD Insulet Corporation Buy 21.32% 5.05%
TVTX Travere Therapeutics, Inc. Buy 7.17% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 5.65% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 19.93% -3.01%
NVCR NovoCure Limited Buy 19.2% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.46% 0%
CDMO Avid Bioservices, Inc. Sell -5.51% 16.54%
STAA STAAR Surgical Company Sell -6.28% 3.86%
AVXL Anavex Life Sciences Corp. Sell -5.37% 12.41%
VREX Varex Imaging Corporation Sell -5.95% 1.28%
CERS Cerus Corporation Sell -5.77% 4.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.59% -1.42%
ORGO Organogenesis Holdings Inc. Buy 10.03% -6.71%
CARA Cara Therapeutics, Inc. Buy 10.06% -6.41%
AGEN Agenus Inc. Buy 9.83% -8.59%
AADI Aadi Bioscience, Inc. Buy 12.72% 2.86%
PODD Insulet Corporation Buy 21.31% 5.72%
TVTX Travere Therapeutics, Inc. Buy 6.44% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 20.4% 0%
NVCR NovoCure Limited Buy 20.39% 0%
CDMO Avid Bioservices, Inc. Sell -5.58% 14.93%
STAA STAAR Surgical Company Sell -6.25% 3.61%
AVXL Anavex Life Sciences Corp. Sell -5.76% 5.44%
VREX Varex Imaging Corporation Sell -6.12% -2.31%
CERS Cerus Corporation Sell -5.9% 1.42%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.25% -5.21%
ORGO Organogenesis Holdings Inc. Buy 10.31% -4.59%
CARA Cara Therapeutics, Inc. Buy 10.15% -6.12%
AGEN Agenus Inc. Buy 9.59% -11.33%
AADI Aadi Bioscience, Inc. Buy 12.8% 2.86%
PODD Insulet Corporation Buy 21.08% 3.96%
TVTX Travere Therapeutics, Inc. Buy 6.55% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 6.23% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 20.52% 0%
CDMO Avid Bioservices, Inc. Sell -5.76% 12.67%
STAA STAAR Surgical Company Sell -6.35% 2.72%
AVXL Anavex Life Sciences Corp. Sell -5.85% 4.42%
VREX Varex Imaging Corporation Sell -6.02% 0%
CERS Cerus Corporation Sell -6.02% 0%
The percentage of cash held in the portfolio is: 22.52%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.53% -2.65%
ORGO Organogenesis Holdings Inc. Buy 10.44% -3.53%
CARA Cara Therapeutics, Inc. Buy 10.45% -3.5%
AGEN Agenus Inc. Buy 9.8% -9.51%
CERS Cerus Corporation Buy 11.46% -7.98%
AADI Aadi Bioscience, Inc. Buy 12.38% -0.57%
PODD Insulet Corporation Buy 20.52% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 18.18% -10.38%
TVTX Travere Therapeutics, Inc. Buy 6.27% 0%
ESPR Esperion Therapeutics, Inc. Buy 6.27% 0%
CDMO Avid Bioservices, Inc. Sell -6.07% 8.03%
STAA STAAR Surgical Company Sell -6.52% 0.15%
AVXL Anavex Life Sciences Corp. Sell -5.69% 7.14%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.91% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.83% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.63% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.66% 3.79%
AGEN Agenus Inc. Buy 9.59% -6.58%
CERS Cerus Corporation Buy 11.12% -5.88%
AADI Aadi Bioscience, Inc. Buy 11.34% -4%
NEOG Neogen Corporation Buy 16.41% -2.15%
PODD Insulet Corporation Buy 19.25% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 19.25% 0%
CDMO Avid Bioservices, Inc. Sell -6.05% 3.4%
STAA STAAR Surgical Company Sell -6.11% 1.42%
PINC Premier, Inc. Sell -6.21% -0.3%
AVXL Anavex Life Sciences Corp. Sell -5.81% 0%
VERU Veru Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • VERU
  • PODD
  • EGRX
Assets Removed
Asset Action Perf %
EGRX Buy All -9.7%
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.75% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.92% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.37% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.46% 4.66%
AGEN Agenus Inc. Buy 10.28% 2.93%
CERS Cerus Corporation Buy 11.2% -2.52%
AADI Aadi Bioscience, Inc. Buy 11.03% -4%
NEOG Neogen Corporation Buy 16.32% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -0.42%
CDMO Avid Bioservices, Inc. Sell -5.93% 2.74%
STAA STAAR Surgical Company Sell -6.03% 0%
PINC Premier, Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 34.64%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.75% 6.09%
ARDX Ardelyx, Inc. Buy 9.67% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.76% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.46% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.54% 7.87%
AGEN Agenus Inc. Buy 10.49% 7.31%
CERS Cerus Corporation Buy 11.24% 0%
AADI Aadi Bioscience, Inc. Buy 11.24% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.79% 0.84%
CDMO Avid Bioservices, Inc. Sell -5.84% 2.08%
The percentage of cash held in the portfolio is: 24.48%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.12% -0.59%
ARDX Ardelyx, Inc. Buy 9.91% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% 0.64%
ORGO Organogenesis Holdings Inc. Buy 10.3% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.09% 1.46%
AGEN Agenus Inc. Buy 10.55% 6.03%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.72% 3.8%
CDMO Avid Bioservices, Inc. Sell -6.07% 0%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.94% -4.32%
ARDX Ardelyx, Inc. Buy 9.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.9% -2.83%
CARA Cara Therapeutics, Inc. Buy 10.2% 0%
AGEN Agenus Inc. Buy 10.2% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.71% 6.33%
The percentage of cash held in the portfolio is: 42.79%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.95% -2.95%
ARDX Ardelyx, Inc. Buy 10.06% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 10.06% 0%
ORGO Organogenesis Holdings Inc. Buy 10.06% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.47% 9.07%
The percentage of cash held in the portfolio is: 62.35%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.15% -1.57%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.75% 4.43%
The percentage of cash held in the portfolio is: 92.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All 0.74%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.24% 7.37%
CYH Community Health Systems, Inc. Buy 12.64% -4.91%
PODD Insulet Corporation Sell -5.81% 6.55%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.17% 13.71%
The percentage of cash held in the portfolio is: 86.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.47% -3.03%
RCM R1 RCM Inc. Buy 12.54% 7.14%
CYH Community Health Systems, Inc. Buy 12.6% -7.66%
PODD Insulet Corporation Sell -6.24% 2.34%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.52% 10.34%
The percentage of cash held in the portfolio is: 76.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.64% -0.76%
RCM R1 RCM Inc. Buy 12.44% 7.06%
CYH Community Health Systems, Inc. Buy 12.83% -5.3%
RMD ResMed Inc. Buy 14.78% 3.67%
PODD Insulet Corporation Sell -6.2% 2.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.62% 8.02%
The percentage of cash held in the portfolio is: 61.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.56% -8.52%
OPK OPKO Health, Inc. Buy 10.84% 2.27%
RCM R1 RCM Inc. Buy 12.39% 7.83%
CYH Community Health Systems, Inc. Buy 13.14% -1.96%
RMD ResMed Inc. Buy 15.15% 7.5%
PODD Insulet Corporation Sell -6.32% -0.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.86% 2.95%
The percentage of cash held in the portfolio is: 51.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.52% -8.24%
OPK OPKO Health, Inc. Buy 11.01% 4.55%
RCM R1 RCM Inc. Buy 12.38% 8.44%
CYH Community Health Systems, Inc. Buy 13.1% -1.57%
HQY HealthEquity, Inc. Buy 12.8% -3.84%
HCSG Healthcare Services Group, Inc. Buy 2.9% -3.72%
RMD ResMed Inc. Buy 14.44% 3.13%
PODD Insulet Corporation Sell -6.3% -1.17%
EGRX Eagle Pharmaceuticals, Inc. Sell -6.05% -0.84%
The percentage of cash held in the portfolio is: 36.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.32% 1.14%
OPK OPKO Health, Inc. Buy 11.13% 7.58%
RCM R1 RCM Inc. Buy 11.09% -1.15%
FATE Fate Therapeutics, Inc. Buy 8.92% -4.31%
CYH Community Health Systems, Inc. Buy 13.52% 3.34%
HQY HealthEquity, Inc. Buy 12.68% -3.09%
HCSG Healthcare Services Group, Inc. Buy 2.92% -1.12%
RMD ResMed Inc. Buy 14.11% 2.5%
PODD Insulet Corporation Sell -6.1% 0.31%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -1.69%
The percentage of cash held in the portfolio is: 27.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 27.55%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.7% 26.42%
PDSB PDS Biotechnology Corporation Buy 10.14% -1.7%
OPK OPKO Health, Inc. Buy 11.34% 8.33%
RCM R1 RCM Inc. Buy 11.23% -1%
FATE Fate Therapeutics, Inc. Buy 8.68% -7.9%
CYH Community Health Systems, Inc. Buy 13.41% 1.38%
HQY HealthEquity, Inc. Buy 12.81% -3.16%
HCSG Healthcare Services Group, Inc. Buy 2.98% -0.43%
RMD ResMed Inc. Buy 13.91% 0%
PODD Insulet Corporation Sell -6.15% 0.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 15.91%
New Assets Added
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.72% 30.89%
PDSB PDS Biotechnology Corporation Buy 10.82% 8.52%
OPK OPKO Health, Inc. Buy 10.96% 8.33%
RCM R1 RCM Inc. Buy 10.69% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 10.27% -4.26%
SMTI Sanara MedTech Inc. Buy 12.09% -5.45%
CYH Community Health Systems, Inc. Buy 13.02% 1.77%
HQY HealthEquity, Inc. Buy 12.57% -1.69%
HCSG Healthcare Services Group, Inc. Buy 2.89% 0%
PODD Insulet Corporation Sell -5.89% 1.61%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.02% 26.12%
PDSB PDS Biotechnology Corporation Buy 10.73% 10.23%
OPK OPKO Health, Inc. Buy 11.08% 12.12%
RCM R1 RCM Inc. Buy 10.69% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.69% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.53% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.64% 1.6%
SMTI Sanara MedTech Inc. Buy 12.49% 0%
CYH Community Health Systems, Inc. Buy 12.49% 0%
HQY HealthEquity, Inc. Buy 12.49% 0%
PODD Insulet Corporation Sell -5.79% 0.85%
RMD ResMed Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.86% 23.69%
PDSB PDS Biotechnology Corporation Buy 10.94% 11.93%
OPK OPKO Health, Inc. Buy 10.67% 7.58%
RCM R1 RCM Inc. Buy 10.67% -0.84%
FATE Fate Therapeutics, Inc. Buy 8.66% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.87% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.52% 0%
PODD Insulet Corporation Sell -5.75% 2.09%
The percentage of cash held in the portfolio is: 33.55%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.4% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 10.74% 19.76%
PDSB PDS Biotechnology Corporation Buy 10.69% 6.96%
OPK OPKO Health, Inc. Buy 10.9% 7.58%
RCM R1 RCM Inc. Buy 11.09% 0.92%
FATE Fate Therapeutics, Inc. Buy 8.49% -7%
PTGX Protagonist Therapeutics, Inc. Buy 10.17% 0%
PODD Insulet Corporation Sell -5.98% 0.3%
The percentage of cash held in the portfolio is: 32.5%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
EGRX Sell All 20.09%
ACAD Sell All 16.37%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.91% 28.79%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.58% 14.55%
CYH Community Health Systems, Inc. Buy 10.45% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 10.39% 18.17%
PDSB PDS Biotechnology Corporation Buy 11.78% 20.17%
OPK OPKO Health, Inc. Buy 10.85% 9.09%
RCM R1 RCM Inc. Buy 11.11% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.96% 0%
PODD Insulet Corporation Sell -5.94% -0.92%
The percentage of cash held in the portfolio is: 19.91%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.11% 29.24%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.71% 14.17%
CYH Community Health Systems, Inc. Buy 10.35% 23.44%
VRDN Viridian Therapeutics, Inc. Buy 10.12% 13.4%
PDSB PDS Biotechnology Corporation Buy 11.02% 10.8%
OPK OPKO Health, Inc. Buy 11.16% 10.61%
RCM R1 RCM Inc. Buy 11.18% 2.15%
PODD Insulet Corporation Sell -5.95% 0.37%
The percentage of cash held in the portfolio is: 29.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -22.33%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.21% 31.03%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.41% 11.78%
CYH Community Health Systems, Inc. Buy 9.83% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 9.73% 9.54%
PDSB PDS Biotechnology Corporation Buy 10.88% 9.94%
OPK OPKO Health, Inc. Buy 11.34% 12.88%
RCM R1 RCM Inc. Buy 11.11% 2%
FGEN FibroGen, Inc. Sell -6.36% -1.94%
PODD Insulet Corporation Sell -5.94% -0.04%
The percentage of cash held in the portfolio is: 36.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.98% 28.57%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.55% 13.35%
CYH Community Health Systems, Inc. Buy 9.81% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 9.71% 9.54%
PDSB PDS Biotechnology Corporation Buy 10.83% 9.66%
ALT Altimmune, Inc. Buy 9% -12.43%
OPK OPKO Health, Inc. Buy 11.54% 15.15%
RCM R1 RCM Inc. Buy 10.71% -1.46%
FGEN FibroGen, Inc. Sell -6.29% -0.97%
PODD Insulet Corporation Sell -5.93% 0%
The percentage of cash held in the portfolio is: 28.09%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.05% 33.48%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.41% 15.55%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.83% 10.14%
CYH Community Health Systems, Inc. Buy 9.94% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 9.92% 15.37%
PDSB PDS Biotechnology Corporation Buy 10.91% 13.92%
ALT Altimmune, Inc. Buy 9.98% 0.13%
OPK OPKO Health, Inc. Buy 10.45% 7.58%
WST West Pharmaceutical Services, Inc. Buy 10.24% -1.88%
RCM R1 RCM Inc. Buy 10.54% 0%
FGEN FibroGen, Inc. Sell -6.27% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.92% 33.26%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.09% 13.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.85% 11.57%
CYH Community Health Systems, Inc. Buy 9.73% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 9.46% 11.2%
BHVN Biohaven Ltd. Buy 10.22% 6.27%
PDSB PDS Biotechnology Corporation Buy 11.37% 20.03%
ALT Altimmune, Inc. Buy 10.41% 5.61%
OPK OPKO Health, Inc. Buy 10.41% 8.33%
WST West Pharmaceutical Services, Inc. Buy 9.91% -3.96%
FGEN FibroGen, Inc. Sell -6.15% -2.91%
The percentage of cash held in the portfolio is: 2.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
Assets Rebalanced
Asset Action Weight
WST Sell -1.07%
CYH Sell -1.56%
VRDN Sell -2.19%
ALT Sell -1.6%
OPK Sell -1.91%
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.09% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.17% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.15% 13.27%
CYH Community Health Systems, Inc. Buy 11.17% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 11.17% 5.15%
OPK OPKO Health, Inc. Buy 12.07% 4.55%
ALT Altimmune, Inc. Buy 12.19% 5.61%
BHVN Biohaven Ltd. Buy 10.27% 5.28%
PDSB PDS Biotechnology Corporation Buy 11.17% 16.19%
WST West Pharmaceutical Services, Inc. Buy 11.24% -3.1%
FGEN FibroGen, Inc. Sell -6.12% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -7.57% -8.93%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
Assets Rebalanced
Asset Action Weight
BHVN Sell -1.88%
RARE Sell -2.22%
EGRX Sell -2.15%
PDSB Sell -2.24%
CYH Sell -3.95%
VRDN Sell -4.24%
WST Buy 8.21%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.27% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.64% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.3% 10.14%
CYH Community Health Systems, Inc. Buy 15.09% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 14.69% -1.97%
PDSB PDS Biotechnology Corporation Buy 13.01% 10.23%
BHVN Biohaven Ltd. Buy 12.38% 4.89%
ALT Altimmune, Inc. Buy 12.12% 2.67%
OPK OPKO Health, Inc. Buy 12.25% 3.79%
WST West Pharmaceutical Services, Inc. Buy 3.12% 0%
FGEN FibroGen, Inc. Sell -5.89% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -8.35% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -7.62% -7.16%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
Asset Action Perf %
NVRO Buy All -10.68%
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.37% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 14.22% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.38% 6.55%
CYH Community Health Systems, Inc. Buy 14.14% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 14.48% -7.12%
PDSB PDS Biotechnology Corporation Buy 12.28% 0%
BHVN Biohaven Ltd. Buy 12.28% 0%
ALT Altimmune, Inc. Buy 12.28% 0%
OPK OPKO Health, Inc. Buy 12.28% 0%
NVRO Nevro Corp. Sell 14.51% -0.63%
FGEN FibroGen, Inc. Sell -5.65% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -7.9% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.63% -3.17%
PAHC Phibro Animal Health Corporation Sell -23.33% 0%
The percentage of cash held in the portfolio is: 14.28%
New Assets Added
  • PAHC
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.24% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.8% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.59% 0.9%
CYH Community Health Systems, Inc. Buy 14.1% 5.31%
VRDN Viridian Therapeutics, Inc. Buy 14.29% -7.27%
NVRO Nevro Corp. Sell 15% -5.28%
FGEN FibroGen, Inc. Sell -4.28% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.13% 2.42%
The percentage of cash held in the portfolio is: 39.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.4% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.18% 16.74%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.81% 2.79%
STAA STAAR Surgical Company Buy 12.09% 5.2%
CYH Community Health Systems, Inc. Buy 14.35% 7.19%
VRDN Viridian Therapeutics, Inc. Buy 14.19% -7.95%
NVRO Nevro Corp. Sell 14.95% -4.9%
FGEN FibroGen, Inc. Sell -4.6% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.05% 3.61%
The percentage of cash held in the portfolio is: 27.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.67% 1.01%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.81% 23.44%
MNKD MannKind Corporation Buy 8.97% -6.26%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.88% 3.19%
STAA STAAR Surgical Company Buy 11.81% 12.05%
CYH Community Health Systems, Inc. Buy 12.75% 3.75%
ARDX Ardelyx, Inc. Buy 14.19% 2.16%
CHRS Coherus BioSciences, Inc. Buy 12.93% -6.94%
NVRO Nevro Corp. Sell 14.15% -8.17%
VRDN Viridian Therapeutics, Inc. Buy 14.15% 0%
FGEN FibroGen, Inc. Sell -4.37% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -5.91% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -6.71% 0%
The percentage of cash held in the portfolio is: -4.3%
New Assets Added
  • APLS
  • NVRO
  • VRDN
Assets Removed
Asset Action Perf %
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.75% 2.33%
MNKD MannKind Corporation Buy 9.16% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.91% 25%
STAA STAAR Surgical Company Buy 11.81% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.82% 3.14%
CYH Community Health Systems, Inc. Buy 12.84% 5%
ARDX Ardelyx, Inc. Buy 13.82% 0%
CHRS Coherus BioSciences, Inc. Buy 13.82% 0%
NVRO Nevro Corp. Sell -6.13% -5.78%
MODV ModivCare Inc. Sell -5.99% -4.83%
FGEN FibroGen, Inc. Sell -5.04% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -6.42% 0%
The percentage of cash held in the portfolio is: 29.65%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.05% 3.09%
MNKD MannKind Corporation Buy 9.5% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.92% 12.05%
STAA STAAR Surgical Company Buy 11.87% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.16% 3.94%
CYH Community Health Systems, Inc. Buy 12.52% 0%
NVRO Nevro Corp. Sell -6.23% -5.03%
MODV ModivCare Inc. Sell -5.9% -0.84%
FGEN FibroGen, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 52.07%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.6% -2.39%
MNKD MannKind Corporation Buy 9.4% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.8% 9.82%
STAA STAAR Surgical Company Buy 11.65% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.02% 1.71%
NVRO Nevro Corp. Sell -6.41% -7.16%
MODV ModivCare Inc. Sell -5.9% 0%
AVXL Anavex Life Sciences Corp. Sell -5.9% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 10.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.86% 0%
NVRO Nevro Corp. Sell -6% 0%
The percentage of cash held in the portfolio is: 45.45%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 6.86%
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Sell -4.48% 11.9%
The percentage of cash held in the portfolio is: 104.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
VKTX Buy All 24.67%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VKTX Viking Therapeutics, Inc. Sell -5.84% 23.65%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.28% 15.79%
The percentage of cash held in the portfolio is: 110.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Buy All 11.45%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RVNC Revance Therapeutics, Inc. Sell -2.82% 12.35%
VKTX Viking Therapeutics, Inc. Sell -6.24% 18.58%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.13% 18.99%
The percentage of cash held in the portfolio is: 113.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 1.76%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 12.38% 8.16%
RVNC Revance Therapeutics, Inc. Sell -2.75% 14.46%
VKTX Viking Therapeutics, Inc. Sell -6.9% 9.85%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.04% 20.59%
The percentage of cash held in the portfolio is: 101.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All 17.73%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 11.35% 14.89%
OMCL Omnicell, Inc. Buy 12.15% 5.58%
RVNC Revance Therapeutics, Inc. Sell -2.72% 15.66%
VKTX Viking Therapeutics, Inc. Sell -7.11% 7.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.91% 23.57%
The percentage of cash held in the portfolio is: 90.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All 5.56%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 14.09% 14.81%
INGN Inogen, Inc. Buy 11.89% 21.99%
OMCL Omnicell, Inc. Buy 12.21% 7.53%
RVNC Revance Therapeutics, Inc. Sell -2.56% 19.58%
VKTX Viking Therapeutics, Inc. Sell -7.18% 5.36%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.52% 10.3%
The percentage of cash held in the portfolio is: 76.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Buy All 15.9%
MDRX Buy All -16.51%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 13.38% 11.11%
INGN Inogen, Inc. Buy 11.95% 24.96%
OMCL Omnicell, Inc. Buy 12.07% 8.3%
NVRO Nevro Corp. Sell -5.88% 17.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.09% -0.53%
RVNC Revance Therapeutics, Inc. Sell -2.55% 18.37%
VKTX Viking Therapeutics, Inc. Sell -6.77% 9.14%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.23% 14.42%
The percentage of cash held in the portfolio is: 91.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -11.24%
SENS Sell All -8.83%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.04% -2.91%
SENS Senseonics Holdings, Inc. Buy 11.34% -7.8%
SGMO Sangamo Therapeutics, Inc. Buy 13.77% 14.81%
INGN Inogen, Inc. Buy 11.14% 17.02%
OMCL Omnicell, Inc. Buy 11.67% 5.21%
NVRO Nevro Corp. Sell -5.85% 17.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.32% -3.46%
RVNC Revance Therapeutics, Inc. Sell -2.5% 19.58%
VKTX Viking Therapeutics, Inc. Sell -6.61% 10.85%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.21% 14.65%
The percentage of cash held in the portfolio is: 68.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.35% 1.85%
SENS Senseonics Holdings, Inc. Buy 11.75% -2.26%
SGMO Sangamo Therapeutics, Inc. Buy 13.89% 18.52%
INGN Inogen, Inc. Buy 11.41% 22.55%
OMCL Omnicell, Inc. Buy 11.61% 7%
VCYT Veracyte, Inc. Buy 10.34% -3.91%
NVRO Nevro Corp. Sell -5.98% 13.34%
MDRX Allscripts Healthcare Solutions, Inc. Sell -8.91% -1.2%
RVNC Revance Therapeutics, Inc. Sell -2.68% 12.05%
VKTX Viking Therapeutics, Inc. Sell -6.62% 8.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.2% 12.81%
The percentage of cash held in the portfolio is: 57.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
ACRS Sell All -8.73%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.33% -0.26%
SENS Senseonics Holdings, Inc. Buy 11.83% -3.49%
SGMO Sangamo Therapeutics, Inc. Buy 13.28% 11.11%
ACRS Aclaris Therapeutics, Inc. Buy 11.19% -6.35%
INGN Inogen, Inc. Buy 11.59% 22.13%
OMCL Omnicell, Inc. Buy 11.71% 5.91%
VCYT Veracyte, Inc. Buy 10.62% -3.2%
PODD Insulet Corporation Buy 19.48% -1.4%
NVRO Nevro Corp. Sell -6.19% 12.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.21% -2.53%
RVNC Revance Therapeutics, Inc. Sell -2.81% 9.34%
VKTX Viking Therapeutics, Inc. Sell -6.88% 6.99%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.91% 0%
The percentage of cash held in the portfolio is: 27.95%
New Assets Added
  • EGRX
Assets Removed
Asset Action Perf %
FOLD Buy All -7.37%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.32% -0.79%
SENS Senseonics Holdings, Inc. Buy 11.86% -3.7%
SGMO Sangamo Therapeutics, Inc. Buy 13.57% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 11.34% -5.56%
INGN Inogen, Inc. Buy 11.85% 24.26%
OMCL Omnicell, Inc. Buy 11.33% 1.99%
VCYT Veracyte, Inc. Buy 10.93% -0.89%
PODD Insulet Corporation Buy 19.72% -0.67%
NVRO Nevro Corp. Sell -6.57% 7.07%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.31% -3.2%
FOLD Amicus Therapeutics, Inc. Sell -3.29% -5.63%
RVNC Revance Therapeutics, Inc. Sell -2.97% 4.82%
VKTX Viking Therapeutics, Inc. Sell -7.26% 2.24%
The percentage of cash held in the portfolio is: 26.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 40.43%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.83% 15.84%
CARA Cara Therapeutics, Inc. Buy 12.41% -0.79%
SENS Senseonics Holdings, Inc. Buy 12.34% -0.41%
SGMO Sangamo Therapeutics, Inc. Buy 14.55% 20.37%
ACRS Aclaris Therapeutics, Inc. Buy 11.42% -5.56%
INGN Inogen, Inc. Buy 12.02% 25.25%
OMCL Omnicell, Inc. Buy 11.3% 1.03%
VCYT Veracyte, Inc. Buy 11.28% 1.69%
PODD Insulet Corporation Buy 20.18% 1.02%
NVRO Nevro Corp. Sell -7.17% -0.71%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.13% -0.53%
FOLD Amicus Therapeutics, Inc. Sell -3.25% -3.68%
RVNC Revance Therapeutics, Inc. Sell -2.85% 9.04%
VKTX Viking Therapeutics, Inc. Sell -7.25% 2.98%
The percentage of cash held in the portfolio is: 12.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.08% 19.11%
CARA Cara Therapeutics, Inc. Buy 13.22% 6.48%
IBRX ImmunityBio, Inc. Buy 10.37% -13.79%
SENS Senseonics Holdings, Inc. Buy 12.44% 1.03%
SGMO Sangamo Therapeutics, Inc. Buy 13.56% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 11.24% -6.35%
INGN Inogen, Inc. Buy 12.1% 26.95%
OMCL Omnicell, Inc. Buy 11.67% 5.08%
VCYT Veracyte, Inc. Buy 11.46% 4%
PODD Insulet Corporation Buy 19.84% 0%
NVRO Nevro Corp. Sell -6.97% 1.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.43% -4.53%
FOLD Amicus Therapeutics, Inc. Sell -3.21% -2.93%
RVNC Revance Therapeutics, Inc. Sell -2.97% 4.82%
VKTX Viking Therapeutics, Inc. Sell -7.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VKTX
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.01% 17.82%
CARA Cara Therapeutics, Inc. Buy 12.54% 0.53%
IBRX ImmunityBio, Inc. Buy 10.88% -9.9%
SENS Senseonics Holdings, Inc. Buy 12.59% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 12.95% 7.41%
ACRS Aclaris Therapeutics, Inc. Buy 11.29% -6.35%
INGN Inogen, Inc. Buy 12.01% 25.39%
OMCL Omnicell, Inc. Buy 11.06% -0.86%
VCYT Veracyte, Inc. Buy 11.59% 4.67%
MD Pediatrix Medical Group, Inc. Buy 13.14% -3.87%
NVRO Nevro Corp. Sell -6.62% 6.71%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.05% 0.13%
FOLD Amicus Therapeutics, Inc. Sell -3.28% -4.66%
RVNC Revance Therapeutics, Inc. Sell -3.12% 0.3%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Buy All -7.43%
Assets Rebalanced
Asset Action Weight
IBRX Sell -1.74%
OMCL Sell -2.4%
PTCT Sell -2.9%
INGN Sell -3.11%
MD Buy 1.37%
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.24% 10.96%
IBRX ImmunityBio, Inc. Buy 13.65% -4%
CARA Cara Therapeutics, Inc. Buy 12.55% -0.79%
SENS Senseonics Holdings, Inc. Buy 11.44% -8.83%
ACRS Aclaris Therapeutics, Inc. Buy 11.46% -6.35%
INGN Inogen, Inc. Buy 15.29% 25.04%
SGMO Sangamo Therapeutics, Inc. Buy 12.46% 1.85%
OMCL Omnicell, Inc. Buy 14.08% 2.22%
MD Pediatrix Medical Group, Inc. Buy 11.23% 0%
VCYT Veracyte, Inc. Buy 11.23% 0%
NVRO Nevro Corp. Sell -6.48% 9.98%
ITGR Integer Holdings Corporation Sell -7.4% -2.84%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.45% -2.8%
FOLD Amicus Therapeutics, Inc. Sell -3.11% 2.06%
RVNC Revance Therapeutics, Inc. Sell -3.18% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.68% 12.88%
IBRX ImmunityBio, Inc. Buy 13.01% -9.68%
CARA Cara Therapeutics, Inc. Buy 12.15% -5.29%
SENS Senseonics Holdings, Inc. Buy 12.17% -4.31%
ACRS Aclaris Therapeutics, Inc. Buy 11.51% -7.14%
INGN Inogen, Inc. Buy 14.88% 20%
SGMO Sangamo Therapeutics, Inc. Buy 12.86% 3.7%
OMCL Omnicell, Inc. Buy 13.95% -0.03%
NVRO Nevro Corp. Sell -6.31% 13.52%
ITGR Integer Holdings Corporation Sell -7.59% -4.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.66% -3.73%
FOLD Amicus Therapeutics, Inc. Sell -3.22% 0%
RVNC Revance Therapeutics, Inc. Sell -3.22% 0%
The percentage of cash held in the portfolio is: 24.79%
New Assets Added
  • FOLD
  • RVNC
Assets Removed
Asset Action Perf %
NUTX Buy All 35.35%
FATE Buy All 34.93%
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.79% 8.68%
IBRX ImmunityBio, Inc. Buy 12.6% -10.34%
CARA Cara Therapeutics, Inc. Buy 12.58% 0.53%
SENS Senseonics Holdings, Inc. Buy 12.25% -1.23%
ACRS Aclaris Therapeutics, Inc. Buy 11.76% -2.78%
INGN Inogen, Inc. Buy 14.91% 23.26%
SGMO Sangamo Therapeutics, Inc. Buy 11.64% -3.7%
IOVA Iovance Biotherapeutics, Inc. Buy 12.61% 7.6%
OMCL Omnicell, Inc. Buy 13.67% 0.4%
NUTX Nutex Health Inc. Sell -3.83% 32.38%
FATE Fate Therapeutics, Inc. Sell -3.52% 37.8%
NVRO Nevro Corp. Sell -6.61% 7.16%
ITGR Integer Holdings Corporation Sell -7.42% -4.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.37% -3.2%
The percentage of cash held in the portfolio is: 14.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.79% 11.27%
IBRX ImmunityBio, Inc. Buy 12.61% -8.12%
CDMO Avid Bioservices, Inc. Buy 13.57% 15.87%
CARA Cara Therapeutics, Inc. Buy 12.8% 4.76%
SENS Senseonics Holdings, Inc. Buy 12.46% 2.87%
ACRS Aclaris Therapeutics, Inc. Buy 12.56% 6.35%
INGN Inogen, Inc. Buy 12.23% 3.55%
SGMO Sangamo Therapeutics, Inc. Buy 11.81% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 12.8% 11.84%
OMCL Omnicell, Inc. Buy 13.37% 0.56%
NUTX Nutex Health Inc. Sell -3.45% 37.6%
FATE Fate Therapeutics, Inc. Sell -3.42% 38.12%
NVRO Nevro Corp. Sell -7.08% -1.86%
ITGR Integer Holdings Corporation Sell -7.18% -3.25%
MDRX Allscripts Healthcare Solutions, Inc. Sell -8.87% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
None
Assets Rebalanced
Asset Action Weight
CDMO Buy 0.57%
OMCL Buy 0.92%
PTCT Buy 1.46%
IOVA Buy 1.74%
CARA Buy 1.82%
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.99% 15.37%
IBRX ImmunityBio, Inc. Buy 12.16% -13.13%
CARA Cara Therapeutics, Inc. Buy 11.16% 4.5%
CDMO Avid Bioservices, Inc. Buy 11.99% 11.38%
SENS Senseonics Holdings, Inc. Buy 12.78% 3.49%
INGN Inogen, Inc. Buy 12.28% 1.99%
ACRS Aclaris Therapeutics, Inc. Buy 12.52% 3.97%
SGMO Sangamo Therapeutics, Inc. Buy 11.82% -1.85%
IOVA Iovance Biotherapeutics, Inc. Buy 11.2% 11.04%
OMCL Omnicell, Inc. Buy 11.99% -0.5%
NUTX Nutex Health Inc. Sell -3.89% 31.05%
FATE Fate Therapeutics, Inc. Sell -3.79% 32.7%
NVRO Nevro Corp. Sell -6.98% 1.5%
ITGR Integer Holdings Corporation Sell -7.23% -1.96%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
CARA Sell -1.56%
IOVA Sell -2.18%
CDMO Sell -1.58%
OMCL Sell -1.84%
PTCT Sell -2.18%
IBRX Buy 1.58%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.82% 15.54%
IBRX ImmunityBio, Inc. Buy 12.08% 1.78%
CDMO Avid Bioservices, Inc. Buy 12.95% 9.13%
CARA Cara Therapeutics, Inc. Buy 12.22% 2.94%
SENS Senseonics Holdings, Inc. Buy 12.48% 3.68%
INGN Inogen, Inc. Buy 11.9% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 12.67% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 12.8% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 12.08% 2.93%
OMCL Omnicell, Inc. Buy 13.54% 0%
NUTX Nutex Health Inc. Sell -3.83% 30.35%
FATE Fate Therapeutics, Inc. Sell -3.56% 35.25%
ATRI Atrion Corporation Sell -7.26% -5.05%
NVRO Nevro Corp. Sell -6.89% 0.27%
ITGR Integer Holdings Corporation Sell -7.01% -1.54%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.79% 19.57%
SMMT Summit Therapeutics Inc. Buy 15.07% 21.76%
IBRX ImmunityBio, Inc. Buy 11.66% -5.01%
CDMO Avid Bioservices, Inc. Buy 12.45% 1.46%
CARA Cara Therapeutics, Inc. Buy 12.32% 0.4%
SENS Senseonics Holdings, Inc. Buy 11.83% -4.93%
INGN Inogen, Inc. Buy 12.14% 0%
ACRS Aclaris Therapeutics, Inc. Buy 12.14% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 12.14% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.14% 0%
NUTX Nutex Health Inc. Sell -3.53% 37.91%
FATE Fate Therapeutics, Inc. Sell -3.7% 34.77%
ATRI Atrion Corporation Sell -7.72% -8.07%
NVRO Nevro Corp. Sell -6.57% 8.04%
ITGR Integer Holdings Corporation Sell -7.16% -0.18%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
Asset Action Perf %
OPK Sell All -3.05%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.31% -6.87%
PTCT PTC Therapeutics, Inc. Buy 14.52% 12.53%
SMMT Summit Therapeutics Inc. Buy 13.14% 1.81%
IBRX ImmunityBio, Inc. Buy 11.38% -11.12%
CDMO Avid Bioservices, Inc. Buy 12.92% 0.93%
CARA Cara Therapeutics, Inc. Buy 12.74% -0.53%
SENS Senseonics Holdings, Inc. Buy 12.98% 0%
NUTX Nutex Health Inc. Sell -3.67% 38.01%
FATE Fate Therapeutics, Inc. Sell -3.73% 37%
ATRI Atrion Corporation Sell -7.98% -7.16%
NVRO Nevro Corp. Sell -6.96% 6.54%
ITGR Integer Holdings Corporation Sell -7.59% -1.87%
The percentage of cash held in the portfolio is: 40.95%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.44% -5.34%
PTCT PTC Therapeutics, Inc. Buy 14.45% 12.5%
SMMT Summit Therapeutics Inc. Buy 12.91% 0.52%
IBRX ImmunityBio, Inc. Buy 12.74% 0%
CDMO Avid Bioservices, Inc. Buy 12.74% 0%
CARA Cara Therapeutics, Inc. Buy 12.74% 0%
NUTX Nutex Health Inc. Sell -3.78% 35.86%
FATE Fate Therapeutics, Inc. Sell -3.8% 35.57%
ATRI Atrion Corporation Sell -7.88% -6.33%
NVRO Nevro Corp. Sell -7.48% -0.88%
ITGR Integer Holdings Corporation Sell -7.75% -4.55%
The percentage of cash held in the portfolio is: 53.67%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.7% -3.82%
PTCT PTC Therapeutics, Inc. Buy 12.92% 0%
SMMT Summit Therapeutics Inc. Buy 12.92% 0%
NUTX Nutex Health Inc. Sell -4.02% 32.17%
FATE Fate Therapeutics, Inc. Sell -3.6% 39.39%
ATRI Atrion Corporation Sell -7.46% 0%
NVRO Nevro Corp. Sell -7.46% 0%
ITGR Integer Holdings Corporation Sell -7.46% 0%
The percentage of cash held in the portfolio is: 92.46%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • PTCT
  • SMMT
Assets Removed
Asset Action Perf %
UTHR Buy All -1.8%
ACRS Sell All -4.76%
KIDS Sell All 4.45%
ANGO Sell All 1.93%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 13.05% -3.97%
KIDS OrthoPediatrics Corp. Buy 12.86% 5.11%
ANGO AngioDynamics, Inc. Buy 11.62% 10.7%
OPK OPKO Health, Inc. Buy 11.44% -6.11%
UTHR United Therapeutics Corporation Sell -5.87% -2.33%
NUTX Nutex Health Inc. Sell -3.24% 45.39%
FATE Fate Therapeutics, Inc. Sell -5.34% 10.05%
The percentage of cash held in the portfolio is: 65.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.63% -7.94%
TNDM Tandem Diabetes Care, Inc. Buy 12.84% -2.07%
KIDS OrthoPediatrics Corp. Buy 13.55% 9.67%
ANGO AngioDynamics, Inc. Buy 12.74% 20.18%
OPK OPKO Health, Inc. Buy 11.93% -3.05%
UTHR United Therapeutics Corporation Sell -6% -3.51%
NUTX Nutex Health Inc. Sell -6% 0%
FATE Fate Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 54.31%
New Assets Added
  • NUTX
  • FATE
Assets Removed
None
Assets Rebalanced
Asset Action Weight
UTHR Buy 39.24%
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.8% -5.56%
TNDM Tandem Diabetes Care, Inc. Buy 12.8% -1.16%
KIDS OrthoPediatrics Corp. Buy 12.8% 4.94%
ANGO AngioDynamics, Inc. Buy 12.8% 22.28%
OPK OPKO Health, Inc. Buy 12.8% 5.34%
UTHR United Therapeutics Corporation Sell -44.54% -3.19%
The percentage of cash held in the portfolio is: 80.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
Asset Action Weight
ACRS Sell -31.79%
TNDM Sell -33.87%
KIDS Sell -36.75%
ANGO Sell -44.94%
OPK Sell -76.15%
2024-04-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.41% 23.33%
TNDM Tandem Diabetes Care, Inc. Buy 8.05% -4.65%
KIDS OrthoPediatrics Corp. Buy 8.01% -5.18%
ACRS Aclaris Therapeutics, Inc. Buy 7.97% -5.56%
OPK OPKO Health, Inc. Buy 15.56% 3.05%
UTHR United Therapeutics Corporation Sell -7.85% -1.67%
NUTX Nutex Health Inc. Sell -6.15% 16.84%
The percentage of cash held in the portfolio is: 63.99%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All 7.77%
MCRB Buy All 24.46%
BAX Sell All -0.86%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 17.04% -0.19%
ANGO AngioDynamics, Inc. Buy 9.39% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 8.21% -5.1%
KIDS OrthoPediatrics Corp. Buy 7.96% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 8.37% -3.17%
OPK OPKO Health, Inc. Buy 15.94% 3.05%
SMTI Sanara MedTech Inc. Sell -3.99% 4.29%
MCRB Seres Therapeutics, Inc. Sell -3.15% 24.46%
UTHR United Therapeutics Corporation Sell -7.86% 0.5%
NUTX Nutex Health Inc. Sell -7.49% 1.05%
The percentage of cash held in the portfolio is: 55.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All -0.14%
VCYT Sell All -5.57%
THC Sell All 9.07%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.96% 10.71%
BAX Baxter International Inc. Buy 17.13% 1.3%
OMCL Omnicell, Inc. Buy 17.42% 3.02%
ANGO AngioDynamics, Inc. Buy 8.76% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 8.21% -4.11%
KIDS OrthoPediatrics Corp. Buy 8.33% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 8.56% 0%
VCYT Veracyte, Inc. Buy 8.53% -0.37%
OPK OPKO Health, Inc. Buy 15.31% 0%
SMTI Sanara MedTech Inc. Sell -4.09% 0.92%
MCRB Seres Therapeutics, Inc. Sell -3.14% 24.06%
UTHR United Therapeutics Corporation Sell -7.78% 0.64%
NUTX Nutex Health Inc. Sell -7.5% 0%
The percentage of cash held in the portfolio is: 17.31%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.71% 11.48%
BAX Baxter International Inc. Buy 16.37% -0.58%
OMCL Omnicell, Inc. Buy 17.32% 5.18%
ANGO AngioDynamics, Inc. Buy 8.59% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 8.36% 0.31%
KIDS OrthoPediatrics Corp. Buy 8.39% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 8.21% -1.59%
VCYT Veracyte, Inc. Buy 8.51% 2.03%
ATRI Atrion Corporation Buy 12.15% 0%
OFIX Orthofix Medical Inc. Buy 12.15% 0%
SMTI Sanara MedTech Inc. Sell -4.05% -0.57%
MCRB Seres Therapeutics, Inc. Sell -3.08% 23.37%
UTHR United Therapeutics Corporation Sell -7.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.74% 11.22%
BAX Baxter International Inc. Buy 16.43% -0.7%
OMCL Omnicell, Inc. Buy 17.41% 5.22%
ANGO AngioDynamics, Inc. Buy 8.38% 0%
TNDM Tandem Diabetes Care, Inc. Buy 8.38% 0%
KIDS OrthoPediatrics Corp. Buy 8.38% 0%
ACRS Aclaris Therapeutics, Inc. Buy 8.38% 0%
VCYT Veracyte, Inc. Buy 8.38% 0%
SMTI Sanara MedTech Inc. Sell -4.1% -1.39%
MCRB Seres Therapeutics, Inc. Sell -3.12% 22.77%
The percentage of cash held in the portfolio is: 18.75%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.57% 8.23%
BAX Baxter International Inc. Buy 16.37% -2.44%
OMCL Omnicell, Inc. Buy 16.86% 0.5%
SMTI Sanara MedTech Inc. Sell -4.17% -1.69%
MCRB Seres Therapeutics, Inc. Sell -3.12% 23.86%
The percentage of cash held in the portfolio is: 61.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Buy All 4.09%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.7% 8.8%
BAX Baxter International Inc. Buy 16.4% -2.7%
OMCL Omnicell, Inc. Buy 16.94% 0.5%
TDOC Teladoc Health, Inc. Sell -7.43% 1.47%
SMTI Sanara MedTech Inc. Sell -4.22% -2.45%
MCRB Seres Therapeutics, Inc. Sell -3.39% 17.72%
The percentage of cash held in the portfolio is: 69%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.59% 8.73%
QTRX Quanterix Corporation Buy 9.68% -3.95%
BAX Baxter International Inc. Buy 16.32% -2.42%
OMCL Omnicell, Inc. Buy 16.63% -0.54%
TDOC Teladoc Health, Inc. Sell -7.19% 3.9%
SMTI Sanara MedTech Inc. Sell -4.14% -1.22%
MCRB Seres Therapeutics, Inc. Sell -3.26% 20.2%
The percentage of cash held in the portfolio is: 59.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Buy All 17.15%
SAVA Buy All -10.84%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.37% 6.46%
QTRX Quanterix Corporation Buy 9.58% -5.31%
BAX Baxter International Inc. Buy 16.21% -3.37%
OMCL Omnicell, Inc. Buy 16.59% -1.15%
SAGE Sage Therapeutics, Inc. Sell -10.58% 16.76%
TDOC Teladoc Health, Inc. Sell -7.26% 3.32%
SMTI Sanara MedTech Inc. Sell -4.06% 1.03%
SAVA Cassava Sciences, Inc. Sell -4.4% -7.26%
MCRB Seres Therapeutics, Inc. Sell -3.08% 24.95%
The percentage of cash held in the portfolio is: 74.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.19% 4.78%
QTRX Quanterix Corporation Buy 9.58% -5.42%
BAX Baxter International Inc. Buy 16.27% -3.21%
OMCL Omnicell, Inc. Buy 16.75% -0.36%
ABUS Arbutus Biopharma Corporation Buy 12.9% -2.96%
SAGE Sage Therapeutics, Inc. Sell -10.92% 14.18%
TDOC Teladoc Health, Inc. Sell -7.27% 3.32%
SMTI Sanara MedTech Inc. Sell -4.13% -0.57%
SAVA Cassava Sciences, Inc. Sell -4.41% -7.31%
MCRB Seres Therapeutics, Inc. Sell -3.2% 22.18%
The percentage of cash held in the portfolio is: 62.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 15.05%
RCM Sell All 21.04%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.45% 14.72%
RCM R1 RCM Inc. Buy 15.42% 22.38%
THC Tenet Healthcare Corporation Buy 12.25% 6.1%
QTRX Quanterix Corporation Buy 9.44% -6.02%
BAX Baxter International Inc. Buy 16.3% -2.26%
OMCL Omnicell, Inc. Buy 16.55% -0.72%
ABUS Arbutus Biopharma Corporation Buy 12.75% -3.33%
SAGE Sage Therapeutics, Inc. Sell -10.75% 14.87%
TDOC Teladoc Health, Inc. Sell -7.08% 5.12%
SMTI Sanara MedTech Inc. Sell -4.03% 1.17%
SAVA Cassava Sciences, Inc. Sell -4.25% -4.28%
MCRB Seres Therapeutics, Inc. Sell -3.07% 24.65%
The percentage of cash held in the portfolio is: 33.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.28% 15.83%
RCM R1 RCM Inc. Buy 15.49% 25.69%
THC Tenet Healthcare Corporation Buy 11.97% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 10.72% -5.05%
QTRX Quanterix Corporation Buy 9.38% -4.49%
BAX Baxter International Inc. Buy 16.27% -0.23%
OMCL Omnicell, Inc. Buy 16.47% 1.04%
ABUS Arbutus Biopharma Corporation Buy 12.85% -0.37%
SAGE Sage Therapeutics, Inc. Sell -10.8% 12.55%
TDOC Teladoc Health, Inc. Sell -7.17% 1.73%
SMTI Sanara MedTech Inc. Sell -3.99% -0.16%
SAVA Cassava Sciences, Inc. Sell -4.18% -4.89%
MCRB Seres Therapeutics, Inc. Sell -3.05% 23.47%
The percentage of cash held in the portfolio is: 22.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.08% 13.88%
RCM R1 RCM Inc. Buy 15.35% 24.26%
THC Tenet Healthcare Corporation Buy 11.84% 4.66%
MRSN Mersana Therapeutics, Inc. Buy 11.01% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.35% 0.33%
QTRX Quanterix Corporation Buy 9.31% -5.45%
BAX Baxter International Inc. Buy 16.64% 1.81%
OMCL Omnicell, Inc. Buy 16.79% 2.73%
ABUS Arbutus Biopharma Corporation Buy 13.07% 1.11%
SAGE Sage Therapeutics, Inc. Sell -11.75% 5.07%
TDOC Teladoc Health, Inc. Sell -7.21% 1.41%
SMTI Sanara MedTech Inc. Sell -3.96% 0.73%
SAVA Cassava Sciences, Inc. Sell -3.78% 5.34%
MCRB Seres Therapeutics, Inc. Sell -3.84% 3.86%
The percentage of cash held in the portfolio is: 12.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All -17.21%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.03% 15.17%
NUTX Nutex Health Inc. Buy 10.4% -13.11%
RCM R1 RCM Inc. Buy 15.45% 27.04%
THC Tenet Healthcare Corporation Buy 11.6% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 10.98% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.41% 2.41%
QTRX Quanterix Corporation Buy 9.69% -0.07%
BAX Baxter International Inc. Buy 16.28% 1.16%
OMCL Omnicell, Inc. Buy 16.25% 0.97%
ABUS Arbutus Biopharma Corporation Buy 12.73% 0%
SAGE Sage Therapeutics, Inc. Sell -11.19% 8.17%
TDOC Teladoc Health, Inc. Sell -7.07% 1.85%
SMTI Sanara MedTech Inc. Sell -3.94% -0.11%
SAVA Cassava Sciences, Inc. Sell -3.82% 2.97%
MCRB Seres Therapeutics, Inc. Sell -3.82% 2.97%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
ATRI Sell All 18.86%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 12.32% 13.11%
BRKR Bruker Corporation Buy 12.98% 13.09%
NUTX Nutex Health Inc. Buy 10.65% -12.3%
RCM R1 RCM Inc. Buy 15.38% 24.71%
THC Tenet Healthcare Corporation Buy 11.67% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 10.92% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.53% 2.02%
QTRX Quanterix Corporation Buy 9.91% 0.75%
BAX Baxter International Inc. Buy 16.32% 0%
OMCL Omnicell, Inc. Buy 16.32% 0%
SAGE Sage Therapeutics, Inc. Sell -11.23% 9.2%
TDOC Teladoc Health, Inc. Sell -6.81% 6.78%
SMTI Sanara MedTech Inc. Sell -3.99% 0%
SAVA Cassava Sciences, Inc. Sell -3.99% 0%
MCRB Seres Therapeutics, Inc. Sell -3.99% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • SAVA
  • MCRB
  • BAX
  • OMCL
Assets Removed
Asset Action Perf %
TVTX Buy All -4.24%
NVTA Buy All 83.05%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 12.79% 17.92%
BRKR Bruker Corporation Buy 12.88% 12.64%
NUTX Nutex Health Inc. Buy 10.71% -11.48%
RCM R1 RCM Inc. Buy 15.37% 25.07%
THC Tenet Healthcare Corporation Buy 11.41% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 10.94% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.05% -1.89%
QTRX Quanterix Corporation Buy 9.85% 0.5%
TVTX Travere Therapeutics, Inc. Sell -5.47% 2.66%
NVTA Invitae Corporation Sell -0.98% 82.49%
SAGE Sage Therapeutics, Inc. Sell -11.24% 8.77%
TDOC Teladoc Health, Inc. Sell -6.69% 7.99%
The percentage of cash held in the portfolio is: 29.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
HAE Buy All -6.69%
NTLA Sell All 19.61%
RGNX Sell All 68.91%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.64% 28.07%
ATRI Atrion Corporation Buy 12.32% 11.54%
RGNX REGENXBIO Inc. Buy 15.62% 46.6%
BRKR Bruker Corporation Buy 13.09% 12.49%
NUTX Nutex Health Inc. Buy 11.51% -6.56%
RCM R1 RCM Inc. Buy 15.67% 25.25%
THC Tenet Healthcare Corporation Buy 11.39% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 11.1% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.69% 1.95%
QTRX Quanterix Corporation Buy 9.98% 0%
TVTX Travere Therapeutics, Inc. Sell -5.67% 0.85%
NVTA Invitae Corporation Sell -1.07% 81.37%
HAE Haemonetics Corporation Sell -5.09% -4.3%
SAGE Sage Therapeutics, Inc. Sell -11.73% 6.45%
TDOC Teladoc Health, Inc. Sell -6.98% 5.82%
The percentage of cash held in the portfolio is: 2.53%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.73% 29.14%
ATRI Atrion Corporation Buy 11.35% 3.03%
RGNX REGENXBIO Inc. Buy 15.45% 45.44%
BRKR Bruker Corporation Buy 12.81% 10.34%
NUTX Nutex Health Inc. Buy 11.38% -7.38%
RCM R1 RCM Inc. Buy 15.64% 25.34%
RVNC Revance Therapeutics, Inc. Buy 11.35% -2.24%
THC Tenet Healthcare Corporation Buy 11.43% 0%
MRSN Mersana Therapeutics, Inc. Buy 11.43% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.43% 0%
TVTX Travere Therapeutics, Inc. Sell -5.43% 4.72%
NVTA Invitae Corporation Sell -1.31% 77.1%
HAE Haemonetics Corporation Sell -5.03% -3.43%
SAGE Sage Therapeutics, Inc. Sell -11.75% 6.06%
TDOC Teladoc Health, Inc. Sell -7.08% 4.09%
The percentage of cash held in the portfolio is: 2.6%
New Assets Added
  • THC
  • MRSN
  • ENTA
Assets Removed
None
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.73% 27.01%
ATRI Atrion Corporation Buy 11.83% 5.65%
RGNX REGENXBIO Inc. Buy 12.93% 19.7%
BRKR Bruker Corporation Buy 12.76% 8.11%
NUTX Nutex Health Inc. Buy 11.57% -7.38%
RCM R1 RCM Inc. Buy 15.96% 25.78%
RVNC Revance Therapeutics, Inc. Buy 11.8% 0%
TVTX Travere Therapeutics, Inc. Sell -5.31% 8.47%
NVTA Invitae Corporation Sell -0.79% 86.42%
HAE Haemonetics Corporation Sell -5.04% -1.79%
SAGE Sage Therapeutics, Inc. Sell -11.74% 7.69%
TDOC Teladoc Health, Inc. Sell -7.24% 3.58%
The percentage of cash held in the portfolio is: 37.52%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.87% 29.7%
ATRI Atrion Corporation Buy 11.53% 4.21%
RGNX REGENXBIO Inc. Buy 14.57% 36.58%
BRKR Bruker Corporation Buy 12.59% 8.03%
NUTX Nutex Health Inc. Buy 11.32% -8.2%
NVAX Novavax, Inc. Buy 12.85% 2.56%
RCM R1 RCM Inc. Buy 16.14% 28.83%
CARA Cara Therapeutics, Inc. Buy 16.51% 38.63%
VRDN Viridian Therapeutics, Inc. Buy 8.31% 0%
TVTX Travere Therapeutics, Inc. Sell -5.4% 5.69%
NVTA Invitae Corporation Sell -0.71% 87.54%
HAE Haemonetics Corporation Sell -5.1% -4.42%
SAGE Sage Therapeutics, Inc. Sell -12.17% 3.09%
TDOC Teladoc Health, Inc. Sell -7.16% 3.52%
The percentage of cash held in the portfolio is: 10.85%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
CUTR Sell All -32.07%
INGN Sell All -38.03%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings